This monoclonal antibody 13F6 that can recognize human Ebola virus glycoprotein may be used for the detection, prevention, and therapeutical threatment of Ebola virus infections in vitro and in vivo.
Figure 1 Immunoprecipitation of 35S- labeled Ebola GPs from supernatants of Vero cells infected with EboGP-VRPs with either the MAb 13F6 (Lane 1) or the MAb 13C6 (Lane 2).
Both preparations contained secreted GP, and sGP. Disulfide-linked GP, and GP2 comprise the spikes on the virions that are also present in the Ebola-infected preparation
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
There are currently no Customer reviews or questions for TAB-262MZ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.